BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32637355)

  • 1. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
    Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
    Front Oncol; 2020; 10():898. PubMed ID: 32637355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
    Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
    J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
    de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
    Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Andersson EI; Brück O; Braun T; Mannisto S; Saikko L; Lagström S; Ellonen P; Leppä S; Herling M; Kovanen PE; Mustjoki S
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32188095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
    Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
    J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
    Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
    Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma.
    Iqbal J; Amador C; McKeithan TW; Chan WC
    Cancer Treat Res; 2019; 176():31-68. PubMed ID: 30596212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
    Ma H; O'Connor OA; Marchi E
    Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
    Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
    Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
    Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
    Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
    Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
    Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Landscape of Peripheral T-Cell Lymphoma.
    Hathuc V; Kreisel F
    Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
    Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
    Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
    Cheng S; Zhang W; Inghirami G; Tam W
    Elife; 2021 Sep; 10():. PubMed ID: 34581268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.
    Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S
    PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.